YZYa-Ru Zheng

Ya-Ru Zheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ya-Ru Zheng has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Li-Fang Ye

    Department of Cardiovascular Sciences, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China

    3 shared publications
  • Lihong Wang

    Heart Center, Department of Cardiovascular Medicine Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College Zhejiang Hangzhou China

    2 shared publications
  • Jian-Wei Fu

    Department of Cardiology, Zhejiang Provincial People's Hospital, China

    1 shared publication
  • Jian-Wu Yu

    Department of Cardiovascular Sciences, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China

    1 shared publication
  • Jing-Yang Lin

    Department of Cardiology, Zhejiang Provincial People's Hospital, China

    1 shared publication
  • Li-Hong Wang

    1 shared publication

Latest Publications

  • Open Access

    Meta-analysis of the association between SCARB1 polymorphism and fasting blood lipid levels

    by Li-Fang Ye, Ya-Ru Zheng, Qing-Gang Zhang, Jian-Wu Yu, Li-Hong Wang

    // <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Li-Fang Ye1, Ya-Ru Zheng1, Qing-Gang Zhang1, Jian-Wu Yu1 and Li-Hong Wang1 1Department of Cardiovascular Sciences, Zhejiang Provincial People’s Hospital, Hangzhou, Zhejiang, China Correspondence to: Li-Hong Wang, email: wanglhnew@126.com Keywords: scavenger receptor class B type 1, polymorphism, lipid, sex Received: December 06, 2016 Accepted: August 26, 2017 Published: September 14, 2017 ABSTRACT Studies have shown that the scavenger receptor class B type 1 (SCARB1) rs5888 polymorphism impacts fasting blood lipid levels differently in men and women. A meta-analysis and statistical tests was therefore performed to determine the relationship between the rs5888 polymorphism and lipid levels in men and women. Twelve studies with 12,147 subjects were selected for this study. In a dominant model, the CT+TT genotype group had lower triglyceride levels than the CC group in men (standardized mean difference (SMD): –0.11; 95% confidence interval (CI): –0.21 to –0.02; P = 0.016; I2 = 51.5%). No statistical differences were detected in women. Subgroup analysis of different racial groups revealed significant correlation between the SCARB1 rs5888 polymorphism and higher high-density lipoprotein cholesterol (HDL-C) levels (SMD: 0.15; 95% CI: 0.08 to 0.21; P ≤ 0.001; I2 = 0%) and lower triglyceride levels (SMD: –0.16; 95% CI: –0.26 to –0.04; P = 0.013; I2 = 60.6%) in non-Asian men. No evidence of heterogeneity was observed when eliminating outlier studies, and no publication bias was detected. This meta-analysis suggests the SCARB1 rs5888 polymorphism is associated with higher HDL-C and lower triglyceride levels in non-Asian men.


  • Low NT-proBNP levels: An early sign for the diagnosis of ischemic heart failure

    by Ya-Ru Zheng, Li-Fang Ye, Xue-Jiang Cen, Jing-Yang Lin, Jian-Wei Fu, Li-Hong Wang


  • Open Access

    Effects of Shenmai injection and its bioactive components following ischemia/reperfusion in cardiomyocytes

    by Li-Fang Ye, Ya-Ru Zheng, Li-Hong Wang

    The aim of the present study was to determine whether the myocardial protective function of Shenmai injection (SM) during ischemia/reperfusion (I/R) is attributable to its regulation of intracellular calcium (Ca2+) and phospholamban (PLB) levels. Cultured neonatal Sprague Dawley rat cardiomyocytes were used to compare the effects of normoxia, total saponins of Panax ginseng (TSPG), ginsenoside Rg1 (Rg1) and SM treatments in rat myocardial cells following I/R. For each of these treatment groups, the mRNA and protein levels of PLB and the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) were evaluated, in addition to the cytoplasmic Ca2+ concentration [Ca2+]i and the rate of apoptosis. The results indicated that I/R markedly decreased phosphorylated PLB and SERCA expression and that SM was able to mitigate this effect, while TPSG and Rg1 were not. Furthermore, SM appeared to prevent aberrant apoptosis and restore the depleted [Ca2+]i resulting from I/R. The protective efficacy of SM against heart disease following I/R may, therefore, be due in part to its effect on intracellular Ca2+ homeostasis. SM may exert its protective effects by relieving PLB inhibition, and the pharmacodynamic actions of SM appear to be significantly more effective than those of its bioreactive components, TPSG and Rgl.


  • (undefined)

    by Ya-Ru Zheng, Zhi-Yun Chen, Li-Fang Ye, Li-Hong Wang